Clinical and pathologic study of abnormal uterine bleeding in premenopausal women to evaluate the prognostic variables of endometrial hyperplasia

Clinical and pathologic study of abnormal uterine bleeding in

premenopausal women to evaluate the prognostic variables of endometrial

hyperplasia

Hoon Cho (1), Ji-Kyung Ko (1), Im-Soon Lee (2), Hong-Kyoon Lee (1)

Department of Obstetrics and Gynecology, Inje University, Sanggye Paik

Hospital, Seoul, Korea (1); Department of Obstetrics and Gynecology,

Soonchunhyang University, Soonchunhyang Hospital, Seoul, Korea (2)

Objective: We performed this study to understand correlation between

clinical aspects and pathological findings of abnormal uterine bleeding (AUB)

and to evaluate the prognostic variables of endometrial hyperplasia.

Method: We reviewed 500 premenopausal women with abnormal uterine

bleeding who underwent endometrial biopsy from January 1996 to February 2003,

retrospectively. Pregnants, women who had hematologic disease, or those who used

iatrogenic hormones were excluded. The age of women with AUB was mostly in the

5th decade (41.3+6.8). Body mass index (BMI) in most of women (69.6%) was

between 18.6 and 24.9 (22.7+3.5).

Results: Among AUB menorrhagia (51.0%) was the most common bleeding

pattern, and the next one was intermenstrual bleeding (38.0%). Histologic

findings of endometrium were proliferative phase (34.0%), hyperplasia (26.4%),

and seceretory phase (22.6%), in order of frequency. 79.0% (104 cases) of

endometrial hyperplasia were simple hyperplasia, 16.0% (21 cases) were complex

hyperplasia, and 5.0% (7 cases) were atypical hyperplasia. The associated

diseases were myoma uteri, hypertension, and diabetes mellitus, in order of

frequency. The endometrial hyperplasia was diagnosed in 46.4% of patients whose

BMI was between 27.0–29.9, in 40% of patients between 30.0–34.9, and in 100%

of patients whose BMI was 35.0 or more. The endometrial hyperplasia was

diagnosed in 40.6% of patients with an endometrial thickness measured 15.1mm to

20.0mm, in 57.1% of patients with 20.1mm to 25.0mm, and in 100% of patients with

25.1mm or higher.

Conclusion: In premenopausal woman with AUB, the endometrial

hyperplasia was highly associated with women whose BMI was 27.0 or higher, or

with endometrial thickness measured more than 15.0mm. Therefore endometrial

biopsy should be taken in women with AUB whose BMI is high, or endometrial

thickness is thick to exclude the endometrial hyperplasia.

Scroll to Top